文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

基于乳酸轨迹的脓毒症心肌病表型及其与28天死亡率的关系:多中心回顾性队列研究

[Lactate trajectory-based phenotypes and their association with 28-day mortality in septic cardiomyopathy: a multicenter retrospective cohort study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论多中心回顾性队列显示,脓毒症心肌病患者按乳酸轨迹可分为4种表型,28天死亡率从9.2%至68.2%递增,表型3和4为独立死亡危险因素。

该多中心回顾性队列纳入3家三级医院ICU收治的216例脓毒症心肌病患者,采用潜类别增长模型基于入ICU首次及确诊后7天内每日乳酸值识别出4种乳酸轨迹表型。4种表型28天死亡率呈显著递增趋势(9.2%、21.9%、30.0%、68.2%,P<0.05)。多因素Cox回归显示表型3(HR=2.831,95%CI 1.243-6.447)和表型4(HR=2.389,95%CI 1.223-4.663)是28天死亡的独立危险因素。据此将患者分为高危(高水平缓慢下降)、中危(中等水平缓慢上升)和低危(中等水平快速下降及持续低水平)三层,为预后评估和个体化治疗提供新思路。

要点

  • 216例脓毒症心肌病患者中,4种乳酸轨迹表型28天死亡率分别为9.2%、21.9%、30.0%、68.2%,呈显著递增趋势(P<0.05)。
  • 表型3(中等水平缓慢上升,n=20)是多因素Cox回归中28天死亡的独立危险因素(HR=2.831,95%CI 1.243-6.447)。
  • 表型4(高水平缓慢下降,n=22)也是独立危险因素(HR=2.389,95%CI 1.223-4.663),且死亡风险显著高于表型3(P<0.05)。
  • 以表型1(持续低水平,n=142,死亡率9.2%)为基线,表型3和4死亡风险更高,据此分为高危、中危、低危三层。
  • Kaplan-Meier曲线显示住院3周后生存概率逐渐趋于平缓。

适用人群与场景

  • 2019年10月至2024年12月收治于3家三级医院(贵州医科大学附属医院、贵州省人民医院、贵黔国际医院)ICU的脓毒症心肌病患者。

研究设计与关键结果

  • 多中心回顾性队列研究,纳入216例脓毒症心肌病患者,28天内死亡41例、存活175例。
  • 潜类别增长模型识别出4种乳酸轨迹表型:表型1持续低水平(n=142)、表型2中等水平快速下降(n=32)、表型3中等水平缓慢上升(n=20)、表型4高水平缓慢下降(n=22)。
  • 4种表型28天死亡率分别为9.2%、21.9%、30.0%、68.2%,呈显著递增趋势(P<0.05)。
  • 单因素Cox回归显示表型3和表型4与28天死亡率相关(均P<0.05);多因素Cox回归显示表型3(HR=2.831,95%CI 1.243-6.447)和表型4(HR=2.389,95%CI 1.223-4.663)为独立危险因素(均P<0.05)。
  • Kaplan-Meier生存曲线显示住院3周后生存概率逐渐趋于平缓;以表型1为基线,表型3和4死亡风险更高,表型4风险显著高于表型3(P<0.05)。
  • 据此将4组分为高危(高水平缓慢下降)、中危(中等水平缓慢上升)、低危(中等水平快速下降及持续低水平)。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于乳酸轨迹识别的4种表型与28天死亡率密切相关,可用于风险分层,为脓毒症心肌病的预后评估和个体化治疗提供新思路。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate phenotypic classification based on plasma lactate trajectories and its association with 28-day mortality in patients with septic cardiomyopathy (SCM).

METHODS: A multicenter retrospective cohort study was conducted. Patients with SCM admitted to the intensive care units (ICUs) of three tertiary hospitals (Affiliated Hospital of Guizhou Medical University, Guizhou Provincial People's Hospital, and GuiQian International Hospital) from October 2019 to December 2024 were enrolled. Baseline characteristics, intervention strategies, and clinical outcomes were collected, including the first blood lactate level upon ICU admission and daily lactate values within 7 days after SCM diagnosis. The primary outcome was 28-day mortality, and secondary outcomes included 28-day vasoactive drug-free days, duration of mechanical ventilation, and ICU length of stay. Latent class growth model (LCGM) was used to identify lactate trajectory-based phenotypes. Differences in the above indicators among phenotypes were compared, and univariate and multivariate Cox regression analyses were performed to identify independent risk factors for 28-day mortality in SCM patients.

RESULTS: A total of 216 SCM patients were included, among whom 41 died and 175 survived within 28 days. LCGM identified four lactate trajectory phenotypes: phenotype 1 (persistent low level, n = 142), phenotype 2 (moderate level with rapid decline, n = 32), phenotype 3 (moderate level with slow increase, n = 20), and phenotype 4 (high level with slow decline, n = 22). The 28-day mortality rates of patients in phenotypes 1-4 showed a significant increasing trend (9.2%, 21.9%, 30.0%, and 68.2%, respectively, P < 0.05). Phenotype 1, which exhibited the lowest mortality and lowest acute physiology and chronic health evaluation (APACHE), was designated as the baseline group. Univariate Cox regression analysis showed that phenotypes 3 and 4 were associated with 28-day mortality in SCM patients (both P < 0.05). Multivariate Cox regression analysis revealed that phenotype 3 [hazard ratio (HR) = 2.831, 95% confidence interval (95%CI) was 1.243-6.447] and phenotype 4 (HR = 2.389, 95%CI was 1.223-4.663) were independent risk factors for 28-day mortality (both P < 0.05). Kaplan-Meier survival curves showed that the survival probability gradually flattened after 3 weeks of hospitalization. Using phenotype 1 as the baseline, patients with phenotypes 3 and 4 had a higher risk of death, and the risk in phenotype 4 was significantly higher than that in phenotype 3 (P < 0.05). Accordingly, the four patient groups were stratified into high-risk (high level with slow decline), intermediate-risk (moderate level with slow increase), and low-risk (moderate level with rapid decline and persistent low level) categories.

CONCLUSIONS: Four phenotypes of SCM were successfully identified based on lactate trajectories, which were closely associated with 28-day mortality and could be used for risk stratification, providing new insights for prognosis assessment and individualized treatment of SCM.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li D, Wu X, Peng Z, et al. [Lactate trajectory-based phenotypes and their association with 28-day mortality in septic cardiomyopathy: a multicenter retrospective cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41500683. doi:10.3760/cma.j.cn121430-20250707-00644

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。